[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Correction
November 1998

Error in Figure

Arch Gen Psychiatry. 1998;55(11):1052. doi:10.1001/archpsyc.55.11.1052

In the article titled "Depressive Signs and Symptoms in Schizophrenia: A Prospective Blinded Trial of Olanzapine and Haloperidol," published in the March 1998 issue of the ARCHIVES (1998;55:250-258), an error appeared in Figure 2 on page 254. The bars for olanzapine and haloperidol should have been separated, the lighter bar representing haloperidol-associated change, and the darker bar, olanzapine-associated change. Figure 2 is reprinted correctly here.

Figure 2.
The individual Montgomery-Asberg Depression Rating Scale (MADRS) item contributions to the total score change. Those with an asterisk represent significant between-treatment differences (items 1-4 and 7), which all favored olanzapine. Asterisk indicates P<.05, F test of treatment effect using analysis of variance.

The individual Montgomery-Asberg Depression Rating Scale (MADRS) item contributions to the total score change. Those with an asterisk represent significant between-treatment differences (items 1-4 and 7), which all favored olanzapine. Asterisk indicates P<.05, F test of treatment effect using analysis of variance.

×